News Category Search | MedStar Health

Featured News

  • September 08, 2021
    MedStar Southern Maryland Hospital Center Welcomes New Interventional Cardiologist Brian Case

    CLINTON, Md. – MedStar Southern Maryland Hospital Center is pleased to welcome Brian C. Case, MD, FACC, a board-certified and fellowship-trained interventional cardiologist who joined the hospital in August 2021.

    Dr. Case, a Montgomery County native, graduated cum laude from St. George's University School of Medicine in 2012 and then participated in an internship at NYU Langone Hospital-Long Island, formerly known as NYU Winthrop Hospital. Dr. Case completed an extensive residency at MedStar Georgetown University Hospital and was selected as the chief medical resident in 2016 for internal medicine. He then obtained fellowship training through a joint program at both MedStar Georgetown University Hospital and MedStar Washington Hospital Center in Washington, D.C., where he was honored as a chief cardiology fellow in 2019, followed by two years of combined research and clinical interventional cardiology.

    As part of the specialty care provided at MedStar Southern Maryland in Clinton, Maryland, Dr. Case treats patients with coronary artery disease through modern technological interventions such as intravascular imaging and invasive physiology to help guide stent selection, placement and deployment. His training includes performing intravascular ultrasound and optical coherence tomography for intravascular imaging, as well as fractional flow reserves and instantaneous wave-free ratios for evaluation of physiological cardiac ischemia.

    “My hope and goal is to incorporate my experience in training into the clinical practice and daily decision making for our patients here at MedStar Southern Maryland,” Dr. Case said. “In the world of interventional cardiology, using intervascular imaging and invasive physiology on a daily basis will help guide treatment plans and allow us to provide more individualized, high-quality heart care. It's about having transparency and innovation that leads to the best possible outcomes for our patients. Because how we treat people is the heart of what matters."

    For appointments with Dr. Case, please call 301-877-5677. To learn more, visit MedStarHealth.org/Case.

    Cardiology MedStar Heart & Vascular Institute

Featured categories

Browse news by hospital

For reporters

Share this

MedStar Health makes the news

All News

  • September 08, 2021
    MedStar Southern Maryland Hospital Center Welcomes New Interventional Cardiologist Brian Case

    CLINTON, Md. – MedStar Southern Maryland Hospital Center is pleased to welcome Brian C. Case, MD, FACC, a board-certified and fellowship-trained interventional cardiologist who joined the hospital in August 2021.

    Dr. Case, a Montgomery County native, graduated cum laude from St. George's University School of Medicine in 2012 and then participated in an internship at NYU Langone Hospital-Long Island, formerly known as NYU Winthrop Hospital. Dr. Case completed an extensive residency at MedStar Georgetown University Hospital and was selected as the chief medical resident in 2016 for internal medicine. He then obtained fellowship training through a joint program at both MedStar Georgetown University Hospital and MedStar Washington Hospital Center in Washington, D.C., where he was honored as a chief cardiology fellow in 2019, followed by two years of combined research and clinical interventional cardiology.

    As part of the specialty care provided at MedStar Southern Maryland in Clinton, Maryland, Dr. Case treats patients with coronary artery disease through modern technological interventions such as intravascular imaging and invasive physiology to help guide stent selection, placement and deployment. His training includes performing intravascular ultrasound and optical coherence tomography for intravascular imaging, as well as fractional flow reserves and instantaneous wave-free ratios for evaluation of physiological cardiac ischemia.

    “My hope and goal is to incorporate my experience in training into the clinical practice and daily decision making for our patients here at MedStar Southern Maryland,” Dr. Case said. “In the world of interventional cardiology, using intervascular imaging and invasive physiology on a daily basis will help guide treatment plans and allow us to provide more individualized, high-quality heart care. It's about having transparency and innovation that leads to the best possible outcomes for our patients. Because how we treat people is the heart of what matters."

    For appointments with Dr. Case, please call 301-877-5677. To learn more, visit MedStarHealth.org/Case.

    Cardiology MedStar Heart & Vascular Institute
  • July 27, 2021
    MedStar Washington Hospital Center Again Named Among Nation’s Best Hospitals for Heart Care

    Only Nationally Ranked Heart Program in the Washington Region

    Washington, D.C. – Once again, MedStar Washington Hospital Center has been recognized among the nation’s top cardiac centers in the 2021-22 U.S. News & World Report “Best Hospitals” rankings. Its Cardiology and Heart Surgery program climbed to No. 30, up seven from last year’s survey. It is the only nationally recognized heart program of its kind in the Washington region. MedStar Washington also received the highest rating possible in aortic valve surgery, heart attack, heart bypass surgery, heart failure, and transcatheter aortic valve replacement (TAVR).

    U.S. News evaluated more than 4,750 medical centers nationwide in 15 specialties and 17 procedures and conditions. In the 15 specialty areas, 175 hospitals were ranked in at least one specialty.

    “Our continuing and ascending stature amongst the best regarded cardiovascular centers in the country is a tribute to the tireless teamwork and dedication of our physicians and associates who strive to put the principle of keeping patients at the heart of everything they do,” said Stuart F. Seides, MD, physician executive director of the MedStar Heart & Vascular Institute. “And to all those patients and their physicians who entrust us with their care, we offer our most sincere gratitude.”

    MedStar Washington Hospital Center, home to MedStar Heart & Vascular Institute, has one of the highest-volume cardiac programs in the nation. It integrates the cardiovascular programs and services of all 10 MedStar Health hospitals and outpatient practices in Maryland, Virginia, and Washington, D.C. Its clinical and research alliance with Cleveland Clinic Heart, Vascular & Thoracic Institute, again ranked No. 1 in the nation by U.S. News, has continued to flourish since 2013.

    U.S. News also cited MedStar Washington’s Urology program as high-performing. Six other common procedures and conditions, chronic obstructive pulmonary disease (COPD), colon cancer surgery, diabetes, kidney failure, pneumonia, and stroke, received the highest ratings, too. "High Performing" is the highest rating U.S. News awards for these types of care that were significantly better than the national average, as measured by factors such as patient outcomes.

     The complete rankings are available at https://health.usnews.com/best-hospitals/rankings.

     

    MedStar Washington Hospital Center is a not-for-profit, 912-bed, teaching and research hospital in the nation’s capital, and is a major referral center for treating the region’s most complex cases. Its cardiology program is highly acclaimed, and its cardiac surgery program has consistently earned the highest national rating–three stars–from the Society of Thoracic Surgeons. MedStar Washington operates the region’s first Comprehensive Stroke Center and the District’s only Cardiac Ventricular Assist Device program, both certified by The Joint Commission. The hospital is also home to MedSTAR, a nationally verified level I trauma center with a state-of-the-art fleet of helicopters and ambulances, and also operates the region’s only adult Burn Center.

    Cardiology Vascular
  • November 02, 2020
    In Gratitude for Lifesaving Stroke Treatment, Financial Services CEO Gifts $4 Million to MedStar Washington Hospital Center

    Washington, D.C., – MedStar Health is honored to announce a generous gift of $4 million from local philanthropists Amy and Alan Meltzer. Mr. Meltzer is CEO and Founder of the NFP | The Meltzer Group, a Bethesda, Md.-based insurance brokerage firm. The gift will support research, training and new technology acquisition for the Comprehensive Stroke Center at MedStar Washington Hospital Center.

    “My wife and I are making this gift in gratitude for the exceptional care I received from the stroke team of doctors and nurses at MedStar Washington Hospital Center,” said Mr. Meltzer. “The treatment they provided helped me to resume a relatively normal life within days of my stroke.”

    Mr. Meltzer was transferred to MedStar Washington Hospital Center after being hospitalized for a stroke in April 2018. Remarkably, only four days after having a stroke, he returned home to his family fully recovered. His lifesaving care experience with the Comprehensive Stroke Center team motivated him to help others who may be afflicted by a stroke. 

    “We are very proud of the amazing care given to all patients by our Comprehensive Stroke Center team,” said MedStar Washington Hospital Center President Gregory J. Argyros, MD. “With vascular disease on the rise, especially with young adults, the generous gift provided by Mr. and Mrs. Meltzer will definitely be put to good use and help us continue to provide the highest quality stroke care to everyone.”

    The Meltzers’ gift will be allocated into three areas: 

    • $1.5 million to support training, education, and certification for nurses
    • $1.25 million to support the acquisition of advanced stroke, neuroscience, and vascular surgery equipment and technology
    • $1.25 million to support neuroscience research

    “We are humbled by this generous gift from Amy and Alan Meltzer in support of MedStar Health and the MedStar Washington Hospital Center Stroke Team that has saved countless lives,” added Kenneth A. Samet, President and Chief Executive Officer of MedStar Health. “Even with today’s advancements in stroke care, this gift allows for the discovery of new diagnostic techniques and treatment options and ultimately, helps stroke survivors thrive.”   

    ###

    About MedStar Washington Hospital Center:
    MedStar Washington Hospital Center is a 912-bed, major teaching and research hospital. It is the largest private, not-for-profit hospital in the nation’s capital, among the 100 largest hospitals in the nation and a major referral center for treating the most complex cases. Its cardiology program is highly acclaimed and its cardiac surgery program has consistently earned the highest national rating–three stars–from the Society of Thoracic Surgeons. The Hospital Center operates the Washington region’s first Comprehensive Stroke Center and the District’s only Cardiac Ventricular Assist Device program, both certified by The Joint Commission. The hospital is also home to MedSTAR, a nationally verified level I trauma center with a state-of-the-art fleet of helicopters and ambulances, and also operates the region’s only adult Burn Center.

    MedStar Health in the Community Vascular
  • August 11, 2020
    MedStar Washington Hospital Center Earns Get With The Guidelines - Stroke Gold Plus Quality Achievement Award
    AHA/ASA Award Recognizes Hospital’s Commitment to Quality Stroke Care
    Healthcare Industry Vascular
  • October 31, 2019
    MedStar Health Gives Infiltrative Cardiomyopathy Patients New Hope for Life
    New Program Will Increase Early Diagnosis, Give Access to Advanced Treatment
    Cardiology Vascular
  • December 06, 2018
    WATCHMAN FLX™ in Clinical Trial at MedStar Heart and Vascular Institute

    Study of Stroke Prevention Device Which May Give Physicians More Flexibility in Optimal Cardiac Positioning

     

    Washington, D.C., June 12, 2018 – MedStar Heart & Vascular Institute physicians participating in a clinical trial have become the first in the Mid-Atlantic region to implant the next generation of a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation (AFib). 

    The next-generation device, called the WATCHMAN FLX™, is being studied for its ability to provide doctors with greater flexibility and safety while positioning the device in the left atrial appendage, a sub-chamber of the heart where blood can pool and form clots. Those clots may then escape into the circulatory system and block blood flow to brain tissue.

    “Our participation in this clinical trial is an example of how the comprehensive AFib program at MedStar Heart & Vascular Institute at MedStar Washington Hospital Center is providing patients with access to cutting-edge devices and treatments before they are widely available,” said Manish Shah, MD, director of the Clinical Cardiac Electrophysiology Fellowship Training Program at the Hospital Center and principal investigator for the new trial.

    MedStar Heart &Vascular Institute is one of approximately 40 sites in the U.S. selected for WATCHMAN FLX implantation, and Dr. Shah is currently the leading implanter of devices nationwide.

    AFib is the most common cardiac arrhythmia in adults, affecting more than five million Americans, and is expected to become even more common as the population ages. AFib causes about 20 percent of all strokes, and strokes from AFib are particularly severe and twice as likely to cause death or incapacitation compared to strokes from other causes.

    Blood thinners are commonly prescribed to patients with AFib to reduce their risk of stroke, but patients and their physicians often have reservations about these types of drugs because of bleeding risks, especially in those patients with an increased risk of falls, along with the potential for medication interactions. As a result, up to 45 percent of patients with AFib may go untreated and unprotected from stroke.

    WATCHMAN FLX is designed to prevent the movement of blood clots formed within the left atrial appendage into the bloodstream, thereby protecting patients from AFib-related strokes.

    “Atrial fibrillation and its consequences are a growing epidemic, especially as our population ages,” said Stuart F. Seides, MD, physician executive director, MedStar Heart & Vascular Institute. “The refinement of a tool that may prevent strokes more securely in more patients is welcome.”

    The first version of WATCHMAN™ became available internationally in 2009, and since then various generations of the device have been implanted more than 50,000 times.

    Patients or physicians interested in learning more about this study and possible participation, please contact clinical study coordinator, Roshila Mohammed, at 202-877-0805.

     

    About MedStar Heart & Vascular Institute
    MedStar Heart & Vascular Institute is a national leader in the research, diagnosis and treatment of cardiovascular disease. A network of 10 hospitals and 150 cardiovascular physicians throughout Maryland, Northern Virginia and the Greater Washington, D.C., region, MedStar Heart also offers a clinical and research alliance with Cleveland Clinic Heart & Vascular Institute, the nation’s #1 heart program. Together, they have forged a relationship of shared expertise to enhance quality, improve safety and increase access to advanced services. MedStar Heart & Vascular Institute was founded at MedStar Washington Hospital Center, home to the Nancy and Harold Zirkin Heart & Vascular Hospital. Opened in July 2016, the hospital ushered in a new era of coordinated, centralized specialty care for patients with even the most complex heart and vascular diagnoses.

    Healthcare Industry Innovation

Other news and publications